NeuroLogica’s OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology.

The world of medical imaging is no longer just black & white. NeuroLogica Corp, a subsidiary of Samsung Electronics, announced today its state-of-the-art OmniTom Elite has received 510(k) clearance for the addition of Photon Counting Detector (PCD) technology. NeuroLogica delivers the first FDA 510(k) cleared, single-source photon counting computed tomography (CT) scanner with single detector. OmniTom Elite with PCD can generate spectral CT images at multiple energy levels.

Photon counting is a next-generation CT technology that sorts the different energies of X-rays after they have passed through the scan field. A single X-ray source paired with PCD generates multiple sets of CT data acquired at the same time with configurable energy thresholds without any cross talk between images. PCD provides the ability to capture CT data in multiple energy bands leading to potentially more accurate visualization and segmentation of bone, blood clots, plaque, hemorrhage and intracranial tumors. There is also potential with PCD to lower the dose requirements, and fundamentally change the use of injected contrast.

“NeuroLogica is driven by innovation. Since the advent of the world’s first multi-slice mobile CT in 2004, we have always known that point-of-care imaging can improve patient outcomes and increase the likelihood of a better quality of life after a traumatic event,” said David Webster, Chief Operating Officer of NeuroLogica. “With the introduction of PCD technology to the OmniTom Elite platform, we look to expand the diagnostic possibilities of CT at the patient’s bedside.”

The OmniTom Elite has the ability to provide versatile, real-time mobile imaging to administer point-of-care CT to critical patients without the need to transport them to a separate imaging department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for these critical patients.

“Availability of photon-counting detector technology on a mobile head CT platform is a significant advance in the development of CT,” said Rajiv Gupta, PhD, MD, Neuroradiology Division Chief of Massachusetts General Hospital and Associate Professor at Harvard Medical School. “This advance heralds a new era of CT applications in stroke, trauma, ICU and intra-op settings.” MGH is collaborating with NeuroLogica and will pilot test the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

Upgrading capabilities were top of mind when designing OmniTom Elite mobile CT scanners. In the near term, all current OmniTom users will have the opportunity to upgrade their scanners with this technology. Meanwhile, a limited number of premier research partners will aid in developing the full potential of OmniTom Elite with PCD.

Neurologica’s OmniTom Elite, and the entire mobile CT product line are manufactured in Danvers, MA, USA.

To stay informed about our PCD products, events and future developments please sign up on our website: https://www.neurologica.com/mobile-ct/PCD

About NeuroLogica

NeuroLogica Corp., the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica is the global corporate headquarters and manufacturer of mobile computed tomography devices. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction and increase workflow efficiency. For more information, please visit: http://www.NeuroLogica.com.

“This has been a momentous year for Samsung. We have worked to advance our solutions by leveraging high computing power and artificial intelligence (AI) technologies,” said David Legg, Vice President, Digital Radiography and Ultrasound, NeuroLogica. “We will be deploying AI features in each of our products to provide benefits to healthcare professionals and patients alike.”

Ultrasound

At the event, Samsung will showcase its new V8, which is a premium ultrasound system that provides enhanced image quality, usability and convenience for ultrasound professionals. Crystal Architecture is the core of the V8’s image clarity and penetration and is built upon the combination of innovative beamforming (CrystalBeam), sophisticated image processing (CrystalLive) and advanced S-Vue Single Crystal Transducers to produce clear, uniform and high-resolution images.

The feature-packed device includes two new AI functions, one being NerveTrack, which detects nerves and provides nerve location information in real-time to anesthesiologists and expert practitioners. The function is designed to provide users with accurate nerve detection, faster image processing and better workflow support. The second AI function is UterineAssist, which detects tissue changes and assists the user in taking measurements of the uterus. With these and other new tools, the V8 delivers a new level of versatility and value to a wide range of diagnostic medical ultrasound departments.

Samsung has also worked to advance its ultrasound solutions for women’s health. Recently, the Hera W9 and W10 received Food and Drug Administration (FDA) 510(K) clearance for its new AI functions, which gives the operator the ability to measure anatomical structures and analyze imaging, providing useful information to aid diagnosis.

New features include:

• HeartAssist: A deep learning-based function that provides classification of ultrasound images to display measurements. The feature recognizes various views and proposes caliper placements and corresponding measurements allowing users to save time with measurement proposals and increase examination efficiency by reducing keystrokes.
• ViewAssist: A deep learning-based function that classifies ultrasound images to deliver key scanning views and provides annotations. The feature recognizes a range of views, proposes corresponding anatomy annotations and initiates measurements.
• BiometryAssist: An automatic solution for biometric measurement that can be modified by the user. It enables users to measure fetal growth parameters with one click while maintaining exam consistency.

Digital Radiography

Samsung is also showcasing its premium digital mobile X-ray, the AccE GM85, which delivers unparalleled performance and gives users better diagnostic confidence while improving workflow. Recently, Samsung received FDA 510(k) clearance for its Auto Lung Nodule Detection (ALND) tool, which can be utilized in the AccE GC85A and in other systems. The ALND is provided as an on-device computer-assisted detection (CADe) software that uses an AI algorithm to detect pulmonary nodules between 10 and 30mm in size.¹

The benefits of ALND include:

• Aids the user in the diagnostic process by indicating the location of suspected lung nodules on chest X-ray images (posteroanterior chest radiographs).
• Offers the option (Autorun) to automatically perform nodule detection immediately after chest X-ray imaging in addition to PACS transmission options to suit the hospital environment, both of which simplify the user’s workflow.
• The ALND has been clinically verified by multiple university hospitals and has been approved with a sensitivity of 80% or more.² As part of Samsung’s commitment to advancing diagnostic radiology using AI, Samsung will expand the uses of the chest CADe solution and continue improving diagnostic accuracy and workflow.

Computed Tomography

Also featured at RSNA is the OmniTom^® Elite – a mobile computed tomography (CT) scanner that delivers high-quality non-contrast CT, CT angiography and CT perfusion scans at point-of-care. The OmniTom Elite CT boasts a small footprint and high-resolution image quality. The advancements of the scanner help to optimize diagnostic confidence, speed and workflow across departments, such as neurosurgery, pediatric imaging, critical care, diagnostic radiology and more.

Earlier this year, NeuroLogica announced that the OmniTom Elite with Photon Counting Detector (PCD) technology will be piloted by Massachusetts General Hospital, bringing CT imaging to the patient’s point-of-care. Pending FDA 510(k) clearance, the hospital is testing the OmniTom Elite with PCD to monitor post-trauma and post-surgical patients.

The OmniTom Elite’s ability to provide versatile, real-time mobile imaging enables healthcare providers to administer point-of-care CT to critical patients without the need to transport them to a separate department. The mobile unit will decrease the time it takes to diagnose and initiate treatment for patients in the ICU. During the pilot stage for the OmniTom Elite with PCD, Massachusetts General Hospital will guide best practices and evaluate use cases for the novel system.

Visit Samsung at Booth #6952.

Samsung will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2021 Annual Meeting.

About Samsung Medison Co., Ltd.

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica Corp.

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

* Content has been updated as of February 10, 2023 to more accurately reflect product information.

¹ ALND cannot be used on patients who have lung lesions other than abnormal nodules.

² Y. Sim et al, Deep Convolutional Neural Network-based Software Improves Radiologist Detection of Malignant Lung Nodules on Chest Radiographs. Radiology, 2020

Samsung Electronics will showcase its premium diagnostic imaging solutions in ultrasound, digital radiography and mobile computed tomography at the Radiological Society of North America (RSNA) 2020 Annual Meeting from November 29 to December 5.

“This year has been a pivotal year for Samsung in moving forwards new solutions across a variety of areas. We are looking forward to putting on display our advancements within ultrasound, digital radiography and mobile CT modalities,” stated Yongkwan Kim, Head of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “Our innovative solutions demonstrate Samsung’s commitment to leveraging our innovation engine to better address the needs of healthcare providers and their patients.”

Ultrasound

Samsung will showcase the RS85 Prestige, which is designed to deliver outstanding scanning performance with consistent image clarity, depth of penetration and sensitivity to perfusion of blood flow to enhance abdominal and breast examination functionality. Above all, the RS85 Prestige delivers real-time images to clinicians, which is essential in ultrasound imaging.

New features:

• EzHRI assists in diagnosing fatty livers by showing the degree of the fatty liver after analyzing the ultrasound images and comparing the brightness level of the automatically selected location of hepatic parenchyma and renal cortex.
• TAI (Tissue Attenuation Imaging), TSI (Tissue Scatter distribution Imaging) provide quantitative tissue attenuation measurement and tissue scatter distribution measurement to assess steatotic liver changes.
• LA2-14A is an S-Vue Transducerwith single crystal technology, providing clear distinction in images of anatomical structures based on high SNR and deep penetration. As a single crystal transducer added to the high-resolution imaging technology, Crystal Architecture, useful images are provided for diagnosing thyroid and breast tumors as well as MSK tendon-related disorders.

Additional features deliver simplified workflow and accurate diagnoses:

• S-Detect simplifies breast examination processes by providing analysis of the selected lesion and standard reporting based on BI-RADS ATLAS*(Breast Imaging-Reporting and Data System, Atlas).
• S-Shearwave Imaging allows for non-invasive assessment of the stiffness of tissue/lesions in applications such as breast, liver, MSK and prostate, aided by color-coded elastogram, quantitative measurements, dual or single display options, and user-selectable ROI functions. It aids in the diagnosis of hepatocirrhosis and tumors.

Digital Radiography

Samsung is showcasing its premium digital mobile x-ray, the AccE GM85, which delivers unparalleled performance by improving diagnostic confidence and workflow. The AccE GM85, powered by a lithium-ion battery, in particular has demonstrated unprecedented performance during the recent pandemic. The AccE GM85 is suited to general imaging needs, and its practicality during the COVID-19 pandemic is highlighted through its unique feature set.

• Fast charging and long-lasting battery allows full charge within four hours, and the power to keep going all day without need for additional charging. With Li-ion battery technology, it offers enhanced stability in wider temperature ranges and its lead-free composition is more friendly for the environment.
• SimGrid streamlines workflow and reduces the total exam time by 28% by omitting grid installation and removal from the conventional workflow.
• S-Vue provides better image quality and significantly reduces radiation dosage during exams. The dosage can be reduced by up to 45% for pediatric abdomen, 15.5% for pediatric chest, and 27% for pediatric skull exams with the new S-Vue engine.¹

Samsung will be introducing two new enhanced software options for its line of DR equipment, including:

• Value Up Package 2021, a suite of workflow enhancement and diagnostic tools for Samsung DR systems including an AI algorithm that automatically provides a heads-up view of chest AP/PA; enhanced S-Align function with information of tube and detector angle to DICOM; and many other tools to deliver improved clinical care.
• Mirror View, real-time wireless screen mirroring to a Smart TV or Miracast-enabled display for use within an ER/Trauma or operating room environment.

Computed Tomography

Featured at RSNA are BodyTom^® Elite and OmniTom^® – mobile whole-body and head CTs. These mobile CTs can be used at the point of care, whenever imaging is needed to determine the ideal treatment strategy for a patient – without restrictions of physical space and power. Samsung’s NeuroLogica mobile CT devices are used by numerous leading institutions in intensive care units, emergency rooms, orthopedic and neurosurgery rooms, brachytherapy suites and ambulances.

In addition, Samsung will be presenting a Photon Counting Detector (PCD)² – cutting-edge technology that measures photons emitted by X-rays. The PCD, currently under development, has the potential to allow for dose optimization, allowing the user to reduce exposure while maintaining image quality, or increase the image quality by keeping dose equivalence compared to currently used CT detectors. The PCD is expected to deliver increased data mining capabilities from multiple-energy detection and contribute to the improved utility and efficacy of AI applications. Expanding from this, Samsung is closely collaborating with a major university hospital in the United States.

Samsung will host three Industry Sessions during RSNA:

• Featured Demonstration about advanced imaging technologies with RS85 Prestige will be held on December 3, from 5:00 p.m. CT – 5:30 p.m. CT.
• AI Theater Presentation: Application of On-Device AI in Healthcare, in collaboration with Intel,³ will discuss On-Device AI solutions that provide real-time feedback on ultrasound images and protect patients’ personal information. As a part of this collaboration, Samsung will host an Industry Session to address the differences between Cloud AI and On-Device AI, and the significance in ultrasound, available on demand throughout the duration of RSNA.
• Innovation Theater will highlight the performance of Auto Lung Nodule Detection (ALND)⁴ imaging application on chest radiographs of COVID-19 patients, available on demand throughout the duration of RSNA.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

¹ The S-Vue outcome is based on limited phantom and clinical study results. Only routine PA chest radiography and abdominal radiography for average adults and pediatric abdominal, chest, skull radiography were studied, excluding pediatric patients under 1 month old. (FDA cleared – K172229, K182183) In practice, the values of dose reduction may vary accordingly.

² Product is under development and not available for sale in USA or any region of the world.

³ Intel, the Intel logo, and other Intel marks are trademarks of Intel Corporation or its subsidiaries.

⁴ ALND is not available for commercial sale in the USA.

“Samsung is continuing its commitment to deliver meaningful innovation in medical imaging, responding to customers’ ever complex healthcare needs,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We plan to continue our rapid pace of new innovation for the radiology market by leveraging our industry leading Image and Signal Processing and AI advances.”

On display at Samsung’s booth during the event are the following technologies:

Ultrasound System

RS85 Prestige¹, the evolution of the RS85, comes with new imaging Architecture and value added features.

RS85 Prestige

Imaging Architecture

• Crystal Architecture – an imaging architecture that combines CrystalBeam beamformer and CrystalPure imaging engine, combined with the S-Vue Transducer which provides crystal clear images.
• CrystalBeam – a new beamforming technology which delivers high-quality image resolution and increased uniformity of images.
• CrystalPure – Samsung’s latest ultrasound imaging engine with enhanced 2D image processing and color signal processing, offering outstanding image performance and efficient workflow in complex cases.

Value Added Features

• MV-Flow with LumiFlow – offers a detailed view of blood flow in relation to the surrounding tissues with enhanced spatial and temporal resolutions and provides three-dimensional visualization with continuous and 3D-like vascular images.
• ShadowHDR – provides a shadow suppressed image, which is especially useful in capturing highly attenuated regions behind bony structures.
• PureVision – an image processing function that produces clear images with uniformity by performing Speckle Noise Suppression and Edge Enhancement on B-mode.

Digital Radiography

Samsung is showcasing its premium ceiling X-ray GC85A and mobile X-ray GM85 which have been granted ATO (Authorization To Operate) for the Risk Management Framework (RMF) program set forth by the United States Department of Defense (DOD) for high level of cybersecurity regulations, while also exhibiting its new detector line-up with enhanced usability.

GM85

• S-Vue – provides high quality images for diagnostic accuracy and confidence. The S-Vue imaging engine’s adaptive filtering and processing technologies reduce X-ray radiation dose for pediatric patients without compromising the image quality. The dose level can be reduced up to 45% for pediatric abdomen, 15.5% for pediatric chest, and 27% for pediatric skull exams with the new S-Vue engine.
• Auto Lung Nodule Detection²– an AI-based CAD (computer-aided detection) software used to identify and detect lung nodules. It is designed to aid the physician in reviewing chest PA radiographs of adults. The new ALND feature is currently available for sale in Europe (CE marked) and Korea.
• SMART Center – an enterprise-level quality asset monitoring solution which aggregates data from multiple Samsung Digital Radiography devices into one easy-to-use platform. Users can reduce downtime and unnecessary tasks by having centralized control over the DR systems.

Computed Tomography

Samsung is highlighting additional mobile computed tomography (mCT) clinical cases demonstrating reduced response time by the medical team during emergencies, such as stroke, improving patient outcomes.

Featured at RSNA are BodyTom^® Elite and OmniTom^® – mobile whole-body and head CT. These mCTs can be used at the point of care, whenever imaging is needed to determine ideal treatment strategy for the patient – without restrictions of physical space and power. Samsung’s NeuroLogica mCT devices are routinely used by leading institutions in intensive care units, emergency rooms, orthopedic and neurosurgery rooms, brachytherapy suites and ambulances. In addition, Samsung Neurologica, in partnership with Winnebago, will be displaying a mobile lung screening vehicle, which will make this technology more accessible in remote areas.

OmniTom®

Lastly, Samsung will display a Photon Counting Detector (PCD)³ – cutting-edge technology that measures photons emitted by X-rays. PCD, currently under development, has the potential to allow for dose optimization allowing the user to reduce the exposure while maintaining image quality, or increase the image quality by keeping dose equivalence compared to currently used CT detectors. In addition, it should deliver increased data mining capabilities from multiple-energy binning and contribute to the improved utility and effectiveness of AI applications.

Visitors can experience Samsung’s differentiated diagnostic assistive functions and solutions directly at booth #4783 (South Building, Hall A).

Additionally, the attendees can also find a separate ‘AI zone’ that allows visitors to experience Samsung’s latest AI technology.

For more information on Samsung’s healthcare business, and products, please visit https://www.samsunghealthcare.com.

About Samsung Medison

Samsung Medison is a global leading medical device company, founded in 1985. With a mission to bring health and well-being of people’s lives, the company manufactures diagnostic ultrasound systems around the world across various medical fields. In 2011, Samsung Medison became an affiliate company of Samsung Electronics, integrating world’s best IT, image processing, semiconductor and communication technologies into medical devices.

About NeuroLogica

NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures, and markets innovative imaging technologies and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. NeuroLogica, the global corporate headquarters and manufacturer of mobile computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. NeuroLogica’s growing portfolio of advanced medical technologies is used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. For more information, please visit http://www.NeuroLogica.com.

¹ RS85 Prestige is 510(k) pending and not available for sale in USA.

² ALND is not for sale in the United States.

³ Product is under development and not available for sale in USA or any region of the world.

The release of OmniTom^® is the latest demonstration of Samsung’s leadership in CT imaging. OmniTom^® features an array of improvements from Samsung’s award-winning CereTom CT scanner, including:

• Improved workflow: OmniTom^® is the world’s first mobile imaging device with omni-directional wheels, maximizing mobility and allowing easier and quieter movement in small spaces.
• Superior image quality: 16-slice (0.625 mm per slice) advanced data acquisition system with a 50 percent increase in CNR versus other portable CT technologies.
• Expanded use: Maintains a small footprint ideal for mobile use while increasing the gantry opening to 40 cm for improved coverage of adult head and neck, and full body pediatric scanning.
• Enhanced safety system: OmniTom^® features an internal drive system, making portability less strenuous, while also offering smart-sensing collision avoidance software to maximize control and patient safety.

OmniTom^® is ideal for cranial procedures and is designed to deliver the highest quality non-contrast CT, CT angiography and CT perfusion scans. The combination of its rapid scan time, ultra-small footprint and immediate image viewing makes OmniTom^® an indispensable tool for collecting real-time data on critically ill patients.

The latest product also demonstrates Samsung’s “AccE” (Access, Accuracy and Efficiency) strategy that aims to change the industry by incorporating innovations in physical access to provide care wherever it is needed. It also aims to improve accuracy in diagnosis with advanced algorithms and efficiency with advanced display, UX and information management technology developed by Samsung Electronics.

“OmniTom^® embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of Access, Accuracy and Efficiency,” said Dongsoo Jun, President of Health & Medical Equipment Business at Samsung Electronics and CEO of Samsung Medison. “We’ve made a CT product that’s lighter, more mobile, more accurate and faster, and we hope the many doctors and technicians here at RSNA will be able to use it to benefit their patients.”

“At Samsung, we work tirelessly to make sure that our full range of products provide patients and physicians with the best possible options for care” added Philip Sullivan, President and CEO Samsung NeuroLogica. “We do this through designing products that deliver broad access, superior accuracy and quality, and make care teams more efficient by maximizing throughput and minimizing waste.”

In addition to OmniTom^®, Samsung will be showcasing its spectral CT with Photon Counting Detector (PCD), the next generation of CT technology. Samsung’s team will also be demonstrating a range of healthcare solutions in mobile CT, Digital Radiography and Ultrasound that are all designed to bridge the care-delivery gap and maximize efficiency to enhance the patient experience. Such solutions include:

• Ultrasound Segment: Samsung will feature their comprehensive general imaging ultrasound portfolio, including the new HS60 and HS40 ultrasound systems which were introduced earlier this year. The RS80A with Prestige, Samsung’s premium general imaging ultrasound system, will be displayed in three daily educational demonstrations featuring live scanning. The RS80A includes innovative technologies for the busy radiology department that help boost clinical confidence. Based on its achievements in ultrasonic diagnosis devices for obstetrics and gynecology, the company is strengthening its premium ultrasonic diagnosis device business for radiology, which has the biggest market potential.

• Digital Radiography Segment: Samsung will display a wide range of its portfolio including two ceiling-mounted systems, GC85 and GC70, as well as highlight its premium portable GM85 X-ray. The GM85’s enhanced mobility and streamlined workflow will enable users to experience a new level of efficiency along with exceptional image quality. Samsung has also differentiated itself from its competitors by adopting low dose technology for enhanced patient safety.

• Magnetic Resonance Imaging Segment: Samsung will be showcasing a prototype of Specialty MRI, an MRI imaging device for arms and/or legs. The prototype is expected to be a game changer in the industry: It is designed to maximize not only cost and space but also patient convenience, as it eliminates the need for the whole body to be in the MRI device.

Learn more by visiting Samsung at booth #2543 (South Building, Hall A) at the RSNA 2017 Annual Meeting, as well as following Samsung NeuroLogica on Facebook, Twitter and LinkedIn.

About Samsung NeuroLogica

Samsung NeuroLogica, the healthcare subsidiary of Samsung Electronics Co., Ltd., develops, manufactures and markets innovative imaging technologies, and is committed to delivering fast, easy and accurate diagnostic solutions to healthcare providers. Samsung NeuroLogica, the global corporate headquarters and manufacturer of Samsung computed tomography, is also the US headquarters for sales, marketing and distribution of all Samsung digital radiography and ultrasound systems. Samsung NeuroLogica’s growing portfolio of advanced medical technologies are used worldwide in leading healthcare institutions helping providers enhance patient care, improve patient satisfaction, and increase workflow efficiency. Samsung is committed to being leaders in the field of healthcare imaging. For more information, please visit www.SamsungNeuroLogica.com.